1.25Open1.41Pre Close1 Volume131 Open Interest6.00Strike Price125.00Turnover133.93%IV0.63%PremiumJul 19, 2024Expiry Date1.22Intrinsic Value100Multiplier5DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type-0.9032Delta0.2219Gamma3.82Leverage Ratio-0.0110Theta-0.0007Rho-3.45Eff Leverage0.0010Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet